Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to brain μ-opioid receptors
Previous studies have established a relationship between sleep disruption and pain, and it has been suggested that hyperalgesia induced by paradoxical sleep deprivation (PSD) could be due to a reduction of opioidergic neurotransmission in the brain. In the present study rats deprived of sleep for 96...
Gespeichert in:
Veröffentlicht in: | Behavioural brain research 2007-03, Vol.178 (2), p.216-220 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Previous studies have established a relationship between sleep disruption and pain, and it has been suggested that hyperalgesia induced by paradoxical sleep deprivation (PSD) could be due to a reduction of opioidergic neurotransmission in the brain. In the present study rats deprived of sleep for 96
h as well as rats allowed to recover for 24
h after PSD and normal controls received vehicle or morphine (2.5, 5 and 10
mg/kg, i.p.) and were tested on a hot plate 1
h later. Quantitative receptor autoradiography was used to map alterations in binding to brain μ-opioid receptors in separate groups. Results demonstrated that PSD induced a significant reduction in thermal pain threshold, as measured by paw withdrawal latencies. This effect did not return to baseline control values after 24
h of sleep recovery. The usual analgesic effect of morphine was observed in the control group but not in PSD or rebound groups except at the highest dose (10
mg/kg). Binding of [
3H]DAMGO to μ sites did not differ significantly among the three groups in any of the 33 brain regions examined. These results do not exclude the participation of the opioid system in PSD-induced pain hypersensitivity since sleep-deprived rats were clearly resistant to morphine. However, the fact no changes were seen in [
3H]DAMGO binding indicates that mechanisms other than altered μ-opioid binding must be sought to explain the phenomenon. |
---|---|
ISSN: | 0166-4328 1872-7549 |
DOI: | 10.1016/j.bbr.2006.12.016 |